Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability
About This Grant
The purpose of the research is to develop methods for evaluating the impact of small design differences in the user interface of generic drug-device combination products when compared to the user interface of the reference listed drug (RLD). The results obtained from this research will be used to gain a better understanding of the factors related to small design differences in the user interface that impact substitutability between generic and branded drug-device combination products in end-user groups.
Grant Summary
Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability is a Food and Drug Administration grant providing funding that varies by award for municipality. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $0K
Rolling / Open
- 1Confirm your organization is eligible for Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability from Food and Drug Administration, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to Food and Drug Administration before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against Food and Drug Administration's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability: Frequently Asked Questions
Who is eligible for the Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability?
Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability is offered by Food and Drug Administration and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability provide?
Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability provides an amount that varies by award per award from Food and Drug Administration. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability deadline?
Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, Food and Drug Administration, before you apply, and submit as early as possible because rolling programs can close once funds are committed.
How do you apply for the Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability?
To apply for Development of methods for evaluating the impact of small design differences in the user interface of drug-device combination products on generic substitutability, confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from Food and Drug Administration.
Browse More Grants
Related Grants
Partnerships for Climate-Smart Commodities Building Markets and Investing in America s Climate-Smart Farmers, Ranchers & Forest Owners to Strengthen U.S. Rural and Agricultural Communities
Natural Resources Conservation Service — up to $100M
Food for Progress Program Notice of Funding Opportunity Fiscal Year 2026
Foreign Agricultural Service — up to $35M
Support for Locally-led Development Approaches Annual Program Statement
Sudan USAID-Khartoum — up to $30M
Research Facilities Act Program
National Institute of Food and Agriculture — up to $30M